Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

Extraordinary General Meeting 2021

November 17, 2021

The shareholders of Nanoform Finland Plc (business ID: 2730572-8) are hereby invited to the Extraordinary General Meeting to be held on 17 November 2021 at 14:00 (EET) at Viikinkaari 4, 00790 Helsinki, Finland (Cultivator II, meeting room 105, 1st floor).

Documents

  • Minutes – Extraordinary general meeting 2021
    English November 17, 2021
  • Pöytäkirja – Ylimääräinen yhtiökokous 2021
    Finnish November 17, 2021
  • Notice to the Extraordinary General Meeting of NANOFORM FINLAND PLC
    English October 18, 2021
  • Kutsu Nanoform Finland OyJ:n ylimääräiseen yhtiökokoukseen
    Finnish October 18, 2021
  • Liite 1 – Appendix 1 Kutsu – Notice to EGM – Optiosopimus – Option Agreement
    English October 18, 2021
  • Liite 2 – Appendix 2 Kutsu – Notice to EGM – Optioehdot – Terms and conditions of stock options 5/2021
    English October 18, 2021
  • Liite 3 – Appendix 3 Kutsu – Notice to EGM – Notice of attendance
    English October 18, 2021
  • Liite 4 – Appendix 4 Kutsu – Notice to EGM -PoA
    English October 18, 2021
  • Liite 5 – Appendix 5 Kutsu – Notice to EGM – PoA by Company
    English October 18, 2021

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8